Nppa

NPPA extends knee implant price ceiling by one year till November 2026

The NPPA has extended the knee implant price cap despite industry requests to remove or relax it, citing rising costs and innovation needs, as the regulator prioritises affordability for patients

NPPA extends knee implant price ceiling till November 2025 amid review

The NPPA has extended the ceiling price for knee implants till November 2025 while considering industry pleas for removal, citing rising costs and supply chain issues

NPPA fixes retail prices for 41 drug combinations, including empagliflozin

The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments, citing steep price drops and growing generic availability

NPPA fixes retail prices of 84 drugs, including empagliflozin combos

The NPPA has fixed retail prices for 84 drug formulations, including 36 combinations of off-patent diabetes drug empagliflozin, after a steep drop in prices

NPPA revises ceiling prices for over 900 drug formulations from April 1

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government

NPPA to allow 1.74% hike in MRP of scheduled drugs in line with WPI rise

With this, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government in this regard

Essential drug price cuts saved patients Rs 3,788 crore a year: Govt

Under the AMRIT initiative, medicines for cancer, cardiovascular diseases, and surgical implants are available at up to 50 per cent discounts in selected hospital pharmacies

NPPA fixes retail prices of 53 drug formulations, including painkillers

The regulatory body, which comes under the Department of Pharmaceuticals (DoP), took the decision to revise the prices of the formulations during the authority's 130th meeting on February 25

NPPA directs pharma firms to update MRP after Budget 2025 duty exemptions

The National Pharmaceutical Pricing Authority directs pharma firms to revise the MRP of medicines following customs duty exemptions in Union Budget 2025, ensuring consumers benefit from lower prices

Medicine retailers, e-pharmacies asked to display DPCO's drug price list

National pharma pricing regulator says list has to be put up 'conspicuously'

NPPA sets prices for 42 drugs, revises ceiling for 2 formulations

Prices have been fixed for drugs and formulations meant for diabetes, hypertension, heart issues, bacterial infections, allergies, and multivitamins

NPPA under fire for 50% rise in drug prices, panel demands explanation

Parliamentary panel slams drug pricing regulator for hike on 11 drugs used for treating conditions such as asthma, glaucoma, thalassemia, tuberculosis, and mental health disorders

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in the National List of Essential Medicines

NPPA raises ceiling prices of 8 scheduled drugs for asthma, TB, glaucoma

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator solution of 5 mg/ml formulation

NPPA fixes retail prices for 54 drug formulations and 8 special products

Prices have been fixed for drugs and formulations meant for diabetes, hypertension, heart issues, multivitamins, bacterial infections, and allergies

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs

Prices of essential drugs such as dapagliflozin metformin hydrochloride, used for lowering blood glucose levels by decreasing glucose production in the liver, have been fixed at Rs 16 per tablet

NPPA revises ceiling prices of 923 scheduled drug formulations from April 1

The formulations in the new revised rate list include essential drugs such as painkillers, antivirals, antibiotics, antimalarials, and drugs for type 2 diabetes

NPP forming govt, border issues, ethnic strife sum up 2023 for Meghalaya

Electoral activities dominated the early part of 2023 in Meghalaya, where the National People's Party formed government with support of the BJP, as the year also remained witness to an MLA's defiant fast over a reservation policy, interstate border issues and ethnic strife. Led by its charismatic young leader Conrad K Sangma, the NPP bagged 26 seats in the 60-member House, seven more than what the party had managed in the 2018 assembly polls. The NPP got another shot in the arm in May, when the People's Democratic Front (PDF), along with two MLAs, merged with it, increasing the ruling party's tally to 28. Despite Prime Minister Narendra Modi and top central ministers campaigning for the BJP, the saffron party could only retain the two seats it had won in 2018. The Opposition Congress and the TMC secured five seats each, while the newly floated Voice of the People Party (VPP) won four. Within months of formation of the new government, VPP chief Ardent Basaiawmoit began a fast that

BJP ally NPP to oppose implementation of Uniform Civil Code in Arunachal

The Arunachal Pradesh unit of the National People's Party (NPP) has decided to oppose the immediate implementation of the Uniform Civil Code (UCC) in the northeastern state. The decision was taken at the state executive meeting of the party here on Saturday, NPP state general secretary Paknga Bage said. NPP state working president Likha Saaya told reporters, "Though NPP is in alliance with the BJP on developmental issues, but the regional party follows its own ideology". The party unanimously adopted a resolution at the meeting opposing the UCC, citing the state's diverse multi-ethnic and multi-tribal composition, as well as its strong customary and traditional identity, Bage said. Elaborating the reason as to why NPP is opposing UCC, Bage said since Arunachal Pradesh has its own unique laws, the NPP has unanimously adopted a resolution to go with the customary laws with certain modifications. "The state and the central governments should focus on codifying the existing customary

Medicines for anxiety, diabetes to get cheaper as NPPA fixes ceiling prices

If drug manufacturers are found flouting the ceiling, they will have to deposit the overcharged amount with the Centre